Second Affiliated Hospital, School of Medicine, Zhejiang University
Who can join
Adults 14 to 90, any sex, with Nutrition, Enteral. Patients with the condition only — healthy volunteers not accepted.
Results — posted to ClinicalTrials.gov
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
the Ratio of the Enteral NutritionPrimary· 3 days after receiving enteral nutrition
the ratio of the enteral nutrition=administered volume of enteral nutrition / prescribed volume of nutrition X 100%; This ratio fluctuates between 0 and 100%, and the higher the ratio, the higher the execution rate
Group
Value
95% CI
Intermittent Feeding With Semi-solid Nutrients
0.98
± 0.067
Standard Enteral Feeding
0.73
± 0.15
the Patient of Feeding Intolerance(FI)Secondary· 3 days
the definition of FI was included one of the conditions:diarrhea, vomiting, regurgitation, obvious bowel distension and GRV\>200mL.
Due to the small sample size, only the number of patients who occurred was recorded.
Group
Value
95% CI
Intermittent Feeding
8
Intermittent Feeding With Semi-solid Nutrients
2
the Patients With Lung InfectionSecondary· 7 days
patient contain the following three conditions:
1.Sputum volume increased or Sputum properties change;2.CT Scan-Chest suggest that there was lung infection; 3.CRP and / or PCT increased
Group
Value
95% CI
Intermittent Feeding
8
Intermittent Feeding With Semi-solid Nutrients
7
30-days MortalitySecondary· 30 days
dead within 30 days in ICU
The number of deaths within 30 days after ICU
Group
Value
95% CI
Intermittent Feeding With Semi-solid Nutrients
3
Intermittent Feeding
2
The number of live after 30 days in ICU
Group
Value
95% CI
Intermittent Feeding With Semi-solid Nutrients
11
Intermittent Feeding
12
the Glycemic Variability(GV)Secondary· 3 days
Divided into three grades:I:GV less than 4mmol/24h; II 4-6mmol/24h;III more than 6mmol/24h
1d-0h
Group
Value
95% CI
Intermittent Feeding With Semi-solid Nutrients
7.514
± 2.2309
Intermittent Feeding
8.457
± 2.9456
1d-4h
Group
Value
95% CI
Intermittent Feeding With Semi-solid Nutrients
8.336
± 2.1653
Intermittent Feeding
9.700
± 3.1001
1d-8h
Group
Value
95% CI
Intermittent Feeding With Semi-solid Nutrients
9.229
± 3.2587
Intermittent Feeding
9.664
± 3.1023
1d-12h
Group
Value
95% CI
Intermittent Feeding With Semi-solid Nutrients
9.342857
± 3.1353357
Intermittent Feeding
8.985714
± 3.2846630
1d-16h
Group
Value
95% CI
Intermittent Feeding With Semi-solid Nutrients
8.635714
± 2.4069154
Intermittent Feeding
8.992857
± 3.1086639
1d-20h
Group
Value
95% CI
Intermittent Feeding With Semi-solid Nutrients
8.064286
± 1.9727400
Intermittent Feeding
8.721429
± 2.5137097
2d-0h
Group
Value
95% CI
Intermittent Feeding With Semi-solid Nutrients
8.436
± 2.2016
Intermittent Feeding
8.686
± 2.9493
2d-4h
Group
Value
95% CI
Intermittent Feeding With Semi-solid Nutrients
8.857
± 2.5687
Intermittent Feeding
9.450
± 3.1889
Length of Hospital Stay (LOS)Secondary· 30 days
every participators stayed in hospital
Group
Value
95% CI
Intermittent Feeding With Semi-solid Nutrients
20.07
± 25.71
Intermittent Feeding
14.36
± 7.59
Sponsor's own description
Malnutrition and underfeeding are major challenges in caring for critically ill patients. Continuous feeding were thought to be better tolerated by patients with the limited absorptive gut surface area or gastrointestinal dysfunction, but associated with more tube clogging and required the patient to be attached to an infusion pump for significant periods of time. Intermittent infusion resembled more physiological feeding process, which allowed greater patient mobility and might reach goal enteral calories earlier, and the latter were considered to effectively decrease the length of stay (LOS)-in-hospital and mortality. However, it also had some previous study found that intermittent infusion had more complications, such as diarrhea, regurgitation than continuous. Some study found that it was an efficient way to prevent aspiration and reflux by increasing the enteral nutrient solution viscosity and improve bolus intermittent feeding intolerance. The primary goal of this was to study whether receiving semi-solidification of nutrients could increase the percent prescribed calories received by improving the feeding intolerance, and secondary goal was to observing the effect of semi-solid nutrient to the LOS of ICU and in-hospital, lung infection, 30-days mortality and the glycemic variability (GV).
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
Other Second Affiliated Hospital, School of Medicine, Zhejiang University trials
Trials by the same sponsor.
NCT07445152 — Research on Construction and Verification of Multimodal Medical Imaging Large Model
· not yet recruiting
NCT06775665 — A Real-World Study on Hypertrophic Cardiomyopathy in Chinese Population
· not yet recruiting
NCT07533422 — Rescue Reatment of Helicobacter Pylori Based on Fecal Antimicrobial Resistance Gene Testing
· NA
· not yet recruiting
NCT07487285 — A Non-inferiority Study of Laser Combined With Ultrasonic Debridement Therapy (LCUDT) Versus Manual Combined With Ultras
· NA
· not yet recruiting
NCT07505186 — Camrelizumab, Chemotherapy and Ivarmacitinib in Patients With Resectable Esophageal Squamous Cell Carcinoma
· Phase 2
· not yet recruiting
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Second Affiliated Hospital, School of Medicine, Zhejiang University
Last refreshed: 2 November 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03017079.